• Company
• Kim Sang-pyo, appointed as Moderna Korea's new GM
• by Eo, Yun-Ho Aug 1, 2024 05:47am

• Company
• Combination cancer immunotherapies show high synergy
• by Son, Hyung-Min Aug 1, 2024 05:47am

• Company
• Commercialization of global RSV vaccines in progress in KOR
• by Son, Hyung-Min Jul 31, 2024 05:52am

• Company
• Competition rises in 1st-line urothelial cell carcinoma mkt
• by Eo, Yun-Ho Jul 31, 2024 05:51am

• Company
• Clinical trials for K-pharma's new lung fibrosis drugs
• by Son, Hyung-Min Jul 31, 2024 05:51am

• Company
• Samsung Bioepis launches Stelara biosimilar Pyzchiva in EU
• by Hwang, Byung-woo Jul 30, 2024 05:52am

• Company
• First patient dosing with Pluvicto imminent in Korea
• by Moon, sunh-ho Jul 30, 2024 05:52am

• Company
• Pfizer's MM drug Elerexfio seeks reimb in KOR
• by Eo, Yun-Ho Jul 29, 2024 05:48am

• Company
• Eylea biosimilar 'Afilivu' will be prescribed
• by Eo, Yun-Ho Jul 29, 2024 05:48am

• Company
• GC accelerates global entry…targets China and Vietnam
• by Her, sung-kyu Jul 29, 2024 05:48am